Graft failure IV. Immunologic mechanisms of corneal transplant rejection

International Ophthalmology

Volumn 28, Issue 3, 2008, Pages 209-222

  Chong, Eva Marie ^a   Dana, Reza M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allosensitization; Corneal transplantation; Immunobiology; Immunologic graft rejection; Ocular immune privilege; Pathophysiologic mechanisms

Indexed keywords

B7 ANTIGEN; CALCINEURIN INHIBITOR; CD86 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; EOTAXIN; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MINOR HISTOCOMPATIBILITY ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; PODOPLANIN; RANTES; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 3; VERY LATE ACTIVATION ANTIGEN 1;

ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; APOPTOSIS; BLOOD GROUP ABO SYSTEM; CLINICAL TRIAL; CORNEA CELL; CORNEA EPITHELIUM; CORNEA TRANSPLANTATION; CYTOKINE RELEASE; ENDOTHELIUM CELL; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HIGH RISK PATIENT; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOGENETICS; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LYMPHANGIOGENESIS; NATURAL KILLER T CELL; NONHUMAN; PATHOPHYSIOLOGY; PENETRATING KERATOPLASTY; REVIEW; RISK FACTOR; RISK REDUCTION; SURGICAL TECHNIQUE;

CORNEA; CORNEAL TRANSPLANTATION; GRAFT REJECTION; HUMANS; IMMUNE SYSTEM;

EID: 43049124189     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10792-007-9099-9     Document Type: Review

References (73)

1. Zirm EK (1906) Eine erfolgreiche totale keratoplastik. Arch Fr Ophthalmol 64:580-593
2. Frequently asked questions (2006) Available at: http://www.restorsight.org/general/faqs.html. Accessed 20 June 2006
3. Coster DJ, Williams KA (2005) The impact of corneal allograft rejection on the long-term outcome of corneal transplantation. Am J Ophthalmol 140:1112-1122
4. Price FW Jr, Whitson WE, Collins KS, Marks RG (1993) Five-year corneal graft survival. A large, single-center patient cohort. Arch Ophthalmol 111:799-805
5. Port FK, Dykstra DM, Merion RM, Wolfe RA (2005) Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 5:843-849
6. Kuchle M, Cursiefen C, Nguyen NX et al (2002) Risk factors for corneal allograft rejection: Intermediate results of a prospective normal-risk keratoplasty study. Graefes Arch Clin Exp Ophthalmol 240:580-584
7. Streilein JW, Yamada J, Dana MR, Ksander BR (1999) Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc 31:1472-1475
8. Thompson RW, Price MO, Bowers PJ, Price FW (2003) Long-term graft survival after penetrating keratoplasty. Ophthalmology 110:1396-1402
9. Ing JJ, Ing HH, Nelson LR et al (1998) Ten-year postoperative results of penetrating keratoplasty. Ophthalmology 105:1855-1865
10. Inoue K, Amano S, Oshika T et al (2000) A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol 44:139-145
11. Williams KA, Muehlberg SM, Bartlett CM et al. (2000) The Australian Corneal graft Registry: 1999 Report. Adelaide, Snap Printing
12. MHC consortium (1999) Complete sequence and gene map of a human major histo-compatability complex. The MHC sequencing consortium. Nature 401:921-923
13. Khodadoust AA, Silverstein AM (1969) Transplantation and rejection of individual cell layers of the cornea. Invest Ophthalmol 8:180-195
14. Khodadoust AA, Silverstein AM (1972) Studies on the nature of the privilege enjoyed by corneal allografts. Invest Ophthalmol 11:137-148 137-148
15. Niederkorn JY (2001) Mechanisms of corneal graft rejection: The sixth annual Thygeson Lecture. Presented at the Ocular Microbiology and Immunology Group Meeting, October 21,2000. Cornea 20:675-679
16. Osawa H, Streilein JW (2005) MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes. Cornea 24:312-318
17. The collaborative corneal transplantation studies (CCTS) (1992) Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol 110:1392-1403
18. Boisjoly HM, Roy R, Bernard PM et al (1990) Association between corneal allograft reactions and HLA compatibility. Ophthalmology 97:1689-1698
19. Sanfilippo F, MacQueen JM, Vaughn WK, Foulks GN (1986) Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation. N Engl J Med 315:29-35
20. Bartels MC, Doxiadis II, Colen TP, Beekhuis WH (2003) Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching. Cornea 22:552-526
21. van Dooremaal IC (1873) Die Entwicklun der in fremden Grund versetzten lebenden Geweba. Graefes Arch Ophthalmol 19:358-373
22. Medawar PB (1948) Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58-69
23. Streilein JW (2003) Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat Rev Immunol 3:879-889
24. Streilein JW, Masli S, Takeuchi T, Kezuka T (2002) The eye's view of antigen presentation. Hum Immunol 63:435-443
25. Niederkorn JY (2003) The immune privilege of corneal grafts. J Leukoc Biol 74:167-171
26. Williams KA, Coster DJ (1985) Penetrating corneal transplantation in the inbred rat: A new model. Invest Ophthalmol Vis Sci 26:23-30
27. Niederkorn JY (2006) See no evil, hear no evil, do no evil: The lessons of immune privilege. Nat Immunol 7:354-359
28. Streilein JW (2003) New thoughts in the immunology of corneal transplantation. Eye 17:943-948
29. Hori J, Streilein JW (2001) Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 42:720-726
30. Cursiefen C, Chen L, Saint-Geniez M et al (2006) Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 103:11405-11410
31. Dana MR, Streilein JW (1996) Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest Ophthalmol Vis Sci 37:2485-2494
32. Maguire MG, Stark WJ, Gottsch JD et al (1994) Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group. Ophthalmology 101:1536-1547
33. Zhivov A, Stave J, Vollmar B, Guthoff R (2005) In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the normal human corneal epithelium. Graefes Arch Clin Exp Ophthalmol 243:1056-1061
34. Hamrah P, Zhang O, Liu Y, Dana MR (2002) Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci 43:639-646
35. Hori J, Wang M, Miyashita M, Tanemoto K, Takahashi H, Takemori T, Okumura K, Yagita H, Azuma M (2006) B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J Immunol 177:5928-5935
36. Huq S, Liu Y, Benichou G, Dana MR (2004) Relevance of the direct pathway of sensitization in corneal transplantation is dictated by graft bed microenvironment. J Immunol 173:4464-4469
37. Simon M, Fellner P, El-Shabrawi Y, Ardjomand N (2004) Influence of donor storage time on corneal allograft survival. Ophthalmology 11:1534-1538
38. He YG, Niederkorn JY (1996) Depletion of donor-derived Langerhans cells promotes corneal allograft survival. Cornea 15:82-89
39. Hamrah P, Liu Y, Zhang Q, Dana MR (2003) The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 44:581-589
40. Mellman I, Steinman RM (2001) Dendritic cells: Specialized and regulated antigen processing machines. Cell 106:255-258
41. Hamrah P, Liu Y, Zhang Q, Dana MR (2003) Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol 121:1132-1140, Erratum in: Arch Ophthalmol 121:1555
42. Gong N, Pleyer U, Yang J, Vogt K et al (2006) Influence of local and systemic CTLA2Ig gene transfer on corneal allograft survival. J Gene Med 8:456-467
43. Yamagami S, Miyazaki D, Ono SF, Dana MR (1999) Differential chemokine gene expression in corneal transplant rejection. Invest Ophthalmol Vis Sci 40:2892-2897
44. Jin Y, Shen L, Chen L et al (2005) Expression of CCR7 by corneal antigen-presenting cells in inflammation. ARVO Abstr 2810/B363
45. Cursiefen C, Cao J, Chen L et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666-2673
46. Cursiefen C, Maruyama K, Jackson DG et al (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25:443-447
47. Cursiefen C, Chen L, Dana MR, Streilein JW (2003) Corneal lymphangiogenesis: Evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22:273-281
48. Allansmith MR, McClellan BH (1975) Immunoglobulins in the human cornea. Am J Ophthalmol 80:123-132
49. Mondino BJ, Brady KJ (1981) Distribution of hemolytic complement in the normal cornea. Arch Ophthalmol 99:1430-1434
50. Yamagami S, Dana MR (2001) The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci 42:1293-1298
51. Yamagami S, Dana MR, Tsuru T (2002) Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk cornea transplantation. Cornea 21:405-409
52. Niederkorn JY, Wang S (2005) Immune privilege of the eye and fetus: parallel universes?. Transplantation 80:1139-1144
53. Chen L, Hamrah P, Cursiefen C et al (2004) Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 10:813-815
54. Streilein JW, Masli S, Takeuchi M, Kezuka T (2002) The eye's view of antigen presentation. Hum Immunol 63:435-443
55. Dana MR, Foster CS (2007) Regulation of immune response. In: Albert DM, Miller JW, Azar DT & Blodi BA (eds) Albert & Jakobiec's principles and practice of ophthalmology, 3rd edn., section 2, chapter 10, Saunders Dec. 2007
56. Streilein JW, Niederkorn JY (1981) Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 153:1058-1067
57. Neiderkorn JY, Mellon J (1996) Anterior-chamber associated immune deviation promotes corneal allograft survival. Invest Ophthalmol Vis Sci 37:2700-2707
58. Niederkorn JY (2006) See no evil, hear no evil, do no evil: The lessons of immune privilege. Nat Immunol 7:354-359
59. Niederkorn JY (2002) Immune Privilege in the anterior chamber of the eye. Crit Rev Immunol 22:13-46
60. Cardell SL (2006) The natural killer T lymphocyte: A player in the complex regulation of autoimmune diabetes in nonobese diabetic mice. Clin Exp Immunol 143:194-202
61. Hargrave SL, Mayhew E, Hegde S, Niederkorn J (2003) Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?. Transplant Immunol 11:79-89
62. Hegde S, Beauregard C, Mayhew E, Niederkorn JY (2005) CD4 (+) T-cell-mediated mechanisms of corneal allograft rejection: Role of Fas-induced apoptosis. Transplantation 79:23-31
63. - T lymphocytes in corneal allograft rejection in 'high-risk' hosts. Am J Transplant 6:705-713
64. Stuart PM, Griffith TS, Usui N et al (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99:396-402
65. Stuart PM, Pan F, Plambeck S, Ferguson TA (2003) FasL-Fas interactions regulate neovascularization in the cornea. Invest Ophthalmol Vis Sci 44:93-98
66. Yamagami S, Kawashima H, Tsuru T et al (1997) Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107-1111
67. Stuart PM, Pan F, Yin X et al (2004) Effect of metalloprotease inhibitors on corneal allograft survival. Invest Ophthalmol Vis Sci 45:1169-1173
68. Jeng BH, Meisler DM, Hollyfield JG et al (2002) Nitric oxide generated by corneas in corneal storage media. Cornea 21:410-414
69. Sagoo P, Chan G, Larkin DF, George AJ (2004) Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci 45:3964-3973
70. Strestikova M, Plskova J, Filipec M, Farghali H (2003) FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice. Nitric Oxide 9:111-117
71. Beauregard C, Huq SO, Barabino S et al (2006) Keratocyte apoptosis and failure of corneal allografts. Transplantation 81:1-6
72. Qian Y, Dekaris J, Yamagami S, Dana MR (2000) Topical soluble tumor necrosis factor receptor type I suppresses ocular chemokine gene expression and rejection of allogeneic corneal transplants. Arch Ophthalmol 118:1666-1671
73. Yamada J, Dana MR, Zhu SN et al (1998) Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol 116:1351-1357